Systematic review and meta-analysis for prevention of cardiovascular complications using GLP-1 receptor agonists and SGLT-2 inhibitors in obese diabetic patients

Patients with type 2 diabetes mellitus (T2DM) and obesity are at high risk of developing cardiovascular disease (CVD). Both glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter (SGLT-2) inhibitors have been shown to prevent CVD in T2DM patients. Additionally, the tw...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Uneda, Kazushi, Kawai, Yuki, Yamada, Takayuki, Kinguchi, Sho, Azushima, Kengo, Kanaoka, Tomohiko, Toya, Yoshiyuki, Wakui, Hiromichi, Tamura, Kouichi
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8119733/
https://ncbi.nlm.nih.gov/pubmed/33986377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-89620-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky